Radiant’s Microreactor Factory Expansion Turns Industrial Scale-Up into an Operating-System Test

Radiant’s Microreactor Factory Expansion Turns Industrial Scale-Up into an Operating-System Test

Industrial factory floor with heavy machinery and marked production lanes, illustrating manufacturing scale-up and process control

ClayoCraft Insights · Business briefing · 20 November 2026

Radiant announced on November 19 that it is expanding its US manufacturing footprint for the Kaleidos transportable microreactor. The plan combines a new headquarters and manufacturing facility in El Segundo, California, with continued development of an 81-acre campus in Oak Ridge, Tennessee. Radiant says the El Segundo site will assemble its first commercial reactors for deliveries beginning in 2028, while Oak Ridge is intended to provide in-house fueling, refueling, storage and high-volume manufacturing capabilities. The company describes more than $100 million of investment in its Los Angeles-area footprint and a planned $280 million Oak Ridge development. For business decision-makers, the announcement is less about a single factory opening than the operating system needed to turn a complex engineered product into a repeatable, regulated manufacturing programme.

What Radiant has announced

The El Segundo expansion adds approximately 200,000 square feet to Radiant’s manufacturing and research footprint. The company says the site will support parallel assembly, reactor-control-system test containers, in-house turbomachinery and power-generation-system production, as well as integrated testing and validation. The Oak Ridge campus is planned to support high-rate manufacturing, fueling, refueling and storage.

Radiant expects its fueling facility to begin operating in 2027 and initial commercial deliveries to begin in 2028. The company says full-scale capacity could reach hundreds of reactors annually, but that is a future target rather than current output. The company also projects more than 300 permanent positions at Oak Ridge over the longer term. Those figures should be read as plans and capacity ambitions, not as completed operating results.

The development sits within a wider commercialization programme. Radiant has described customer interest across defense and commercial markets, progress in testing and a fuel supply chain intended to support future deployments. Those elements are important, but customer agreements and facility investment do not by themselves prove that the product is ready for serial manufacture or that regulatory milestones will be achieved on schedule.

A notable question about the manufacturing sequence

The new announcement describes El Segundo as the location where the first commercial reactors will be assembled, with Oak Ridge providing fueling and high-volume manufacturing capabilities. Independent industry coverage by Voltgrid News noted that Radiant’s October 29 description had referred to its R-50 Oak Ridge facility as the site for building the first commercial units. The November 19 announcement therefore appears to change or clarify the initial assembly sequence.

That does not establish that the plan has been cancelled or that the facilities are in conflict. It does create a practical question that customers, suppliers and project partners should ask: which products, production stages and volumes are assigned to each site during each phase? A multi-site operating model can be effective, but only when engineering authority, configuration control, materials traceability and acceptance testing are clearly allocated.

The company’s latest public description should be treated as the current stated plan, while the difference from its earlier description should remain visible until the company provides more detail. In complex manufacturing, a change in the location of first assembly can affect transport, tooling, workforce training, supplier qualification, test equipment and the handover between facilities.

The operating system behind a complex product

A factory is not a collection of machines. It is a connected system of product configuration, people, suppliers, work instructions, quality records, test procedures, maintenance, safety controls and release authority. A microreactor adds a high level of regulatory and technical scrutiny because components, materials and process records can affect safety and licensing obligations.

The first requirement is configuration control. Engineering must know exactly which design revision is being built, which components are approved and how any change is assessed. Production teams need controlled work instructions and a reliable way to prevent obsolete drawings or parts from entering a build. Suppliers need the same revision discipline so that a material substitution does not create a hidden compliance problem.

The second requirement is traceability. The organisation needs to link incoming materials, supplier certifications, manufacturing steps, inspection results, non-conformances, repairs and final acceptance records to the specific unit. If the information sits in disconnected spreadsheets or email threads, a company may be able to assemble a reactor but struggle to demonstrate that the build followed the approved process.

The third requirement is integrated testing. A component that passes its own inspection may still fail when combined with other systems. Test containers, instrumentation, control software, power-generation equipment and safety systems must be validated as an integrated product. The operating plan should define what is tested at each site, who signs the results and how failures are routed back to design and production.

Fuel logistics and regulatory gates cannot be treated as side projects

Radiant’s two-site model places particular importance on fuel handling and the movement of a factory-sealed product. Fueling and refueling require specialist facilities, trained personnel, controlled materials and documented procedures. The logistics plan must connect production readiness with the availability of approved fuel, packaging, transport, storage and receiving arrangements.

Radiant has said that the US Nuclear Regulatory Commission accepted its application for accelerated review in May 2026 and that it is targeting a decision in January 2027. Acceptance for review is not the same as approval. The company still needs to meet applicable regulatory requirements and demonstrate that the facility, process and responsible organisation are ready for the activities proposed.

A good project schedule should show regulatory gates as real dependencies, not as dates that can be solved by adding labour. It should identify which construction, commissioning, training and supplier-qualification activities can proceed in parallel, and which require a formal approval before work can start. If a licence or inspection takes longer than planned, the business needs a scenario that protects capital and customer commitments without bypassing controls.

The supplier network needs to scale with the design

A complex manufacturing programme depends on more than the final assembly site. Long-lead components, specialized alloys, control systems, instrumentation, turbomachinery and qualified fabrication partners can become constraints. The company should map each critical item to a supplier, approved specification, lead time, inspection requirement and alternate source where one is permitted.

Supplier readiness should be assessed against the actual production ramp. A supplier that can deliver a prototype component may not be able to sustain a repeatable production rate. Qualification needs to include process capability, capacity evidence, quality management, cyber and data controls, financial resilience and the ability to support engineering changes.

The business should also avoid confusing a second supplier with a qualified alternative. In safety-critical manufacturing, an alternate source may need its own technical assessment and approval. Procurement teams should be involved early, but engineering and quality must retain authority over technical acceptance. Commercial pressure should not be allowed to weaken the approved configuration.

Metrics that show whether the ramp is becoming repeatable

The most useful early measures are not simply units assembled or square feet opened. Leaders should track first-pass yield, rework hours, open non-conformances, supplier on-time delivery, incoming inspection failures, engineering-change cycle time, test completion, commissioning defects and training qualification. These measures show whether the process is becoming stable.

Schedule adherence should be measured at the level of critical work packages and dependencies. If a test is delayed because a supplier document is missing, that is different from a test failure caused by a design issue. The programme needs reason codes that distinguish material shortages, engineering changes, quality holds, equipment downtime, staffing gaps and regulatory constraints.

Safety and compliance measures should sit alongside cost and throughput. Track audit findings, corrective-action closure, procedure deviations, material reconciliation, training currency and the time required to close quality issues. A high production rate is not a success if records are incomplete or defects are being pushed into later stages.

Financial measures also need a realistic ramp profile. Capital expenditure, commissioning costs, inventory, supplier deposits and working capital may arrive before customer revenue. Management should model a slower qualification path and a lower early utilisation rate. A factory can be physically complete while its economic output remains constrained by testing, licensing or customer acceptance.

What other manufacturers can learn

The Radiant programme is relevant beyond nuclear energy. Any company moving from prototype to regulated or high-reliability production faces the same basic challenge: repeatability must be designed into the operating model. Aerospace, medical devices, industrial automation, energy equipment and advanced electronics all need configuration control, supplier quality, traceability, test evidence and trained people.

Business leaders should create a single readiness plan that links product design, manufacturing engineering, procurement, quality, regulatory affairs, finance, service and customer delivery. Each workstream should have one accountable owner, clear entry and exit criteria and a documented escalation route. A weekly dashboard should show the few constraints that can change the delivery date or the cost of the programme.

Specialist partners can help with manufacturing engineering, quality systems, programme controls, regulatory preparation, digital manufacturing and workforce training. Co-sourced support is most useful when it fills a defined capability gap and leaves behind documented processes. The company should not outsource the ownership of design authority, safety decisions or final product acceptance.

The commercial milestone is reliable delivery, not a press release

Radiant’s expansion is a meaningful industrial development, but the proof will arrive through commissioning, regulatory progress, qualified supply, integrated testing and customer delivery. The stated 2027 fueling start and 2028 initial deliveries remain company targets. The ambition to produce hundreds of units annually is a longer-term capacity statement, not a current production rate.

For decision-makers evaluating suppliers or new energy systems, the practical response is to ask for a stage-gated readiness plan. It should show what has been built, what has been tested, which approvals remain open, how fuel and components are controlled, and what evidence will be available before a customer accepts a unit. The best manufacturing strategy is the one that can repeat a safe, documented and supportable outcome.

Questions business leaders are asking

Are Radiant’s commercial microreactors already in production?

Radiant has announced facility expansion and a plan to assemble initial commercial units for deliveries beginning in 2028. The company’s statement describes planned capacity and future milestones, not a current high-volume production rate.

What is the difference between the El Segundo and Oak Ridge sites?

Radiant’s November 19 announcement describes El Segundo as the site for initial commercial assembly and Oak Ridge as a campus for fueling, refueling, storage and high-volume manufacturing. The precise phased allocation of work should be confirmed as the programme develops.

Does acceptance of a licence application mean the facility is approved?

No. Acceptance for review means the regulator has accepted the application into its review process. It is not a final licence decision or permission to begin every proposed activity.

Sources and further reading

Editorial note: Facility investments, capacity and delivery dates described as future plans are company statements and targets. Acceptance of a licence application is not a final approval. This article is general business analysis, not nuclear regulatory advice.

Leave a Reply

Your email address will not be published. Required fields are marked *